The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Bristol-Myers Squibb/Celgene; Janssen Oncology; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; Janssen Oncology; Roche
Research Funding - Janssen Oncology (Inst); Novartis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; Janssen Oncology
Subgroup analyses in patients with relapsed/refractory multiple myeloma (RRMM) receiving real-life current standard of care (SOC) in the LocoMMotion study.
 
Hermann Einsele
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb; Celgene (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda; Takeda
 
Philippe Moreau
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; oncopeptides; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; oncopeptides; Sanofi
 
Valerio De Stefano
No Relationships to Disclose
 
Dominik Dytfeld
Honoraria - Amgen; Celgene/Bristol-Myers Squibb; Janssen; Takeda
Consulting or Advisory Role - Amgen; Celgene/Bristol-Myers Squibb; Janssen; Takeda
Research Funding - Celgene; Janssen
 
Emanuele Angelucci
Honoraria - Celgene; Vertex
Consulting or Advisory Role - Bluebird Bio; Novartis
Travel, Accommodations, Expenses - Janssen-Cilag
 
Reuben Benjamin
Consulting or Advisory Role - Allogene Therapeutics; Arovella Therapeutics; Bristol-Myers Squibb; Janssen; Oncopeptides; Secura Bio
Research Funding - Alimera Sciences; SERVIER
 
Hartmut Goldschmidt
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Chugai Pharma; GlaxoSmithKline; Janssen-Cilag; Novartis; Sanofi
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Chugai Pharma Europe (Inst); Incyte (Inst); Janssen (Inst); Molecular Partners (Inst); MSD (Inst); Mundipharma (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Sanofi
Other Relationship - Amgen (Inst); Celgene/Bristol-Myers Squibb (Inst); Chugai Pharma Europe (Inst); Janssen (Inst); Sanofi (Inst)
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Cellectis (Inst); Janssen (Inst)
 
Britta Besemer
Honoraria - Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag
 
Christof Scheid
No Relationships to Disclose
 
Ravi Vij
Consulting or Advisory Role - Adaptive Biotechnologies; BeiGene; Bristol-Myers Squibb/Celgene; CareDX; GlaxoSmithKline; harpoon; Legend Biotech; Oncopeptides; Pfizer; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Dava Oncology; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
 
Ester in ’t Groen-Damen
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Maria Semerjian
Employment - Johnson & Johnson
 
Vadim Strulev
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Jordan Mark Schecter
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
 
Tito Roccia
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Tonia Nesheiwat
Employment - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
 
Robert Wapenaar
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Katja Weisel
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Amgen (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene (Inst); Celgene; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline (Inst); Janssen (Inst); Janssen-Cilag; Karyopharm Therapeutics; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Sanofi (Inst); Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Oncopeptides; Roche; Sanofi; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda